Wysiwyg Studios Co., Ltd. (KOSDAQ:299900)

Ligand Pharmaceuticals Revenue

Wysiwyg Studios had revenue of 20.79B KRW in the quarter ending March 31, 2025, with 22.01% growth. This brings the company's revenue in the last twelve months to 84.18B, down -31.20% year-over-year. In the year 2024, Wysiwyg Studios had annual revenue of 80.43B, down -45.41%.

• Revenue (ttm): 84.18B
• Revenue Growth: -31.20%
• P/S Ratio: 1.78
• Revenue / Employee: 2.90B
• Employees: 29
• Market Cap: 149.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	80.43B	-66.90B	-45.41%
Dec 31, 2023	147.34B	815.04M	0.56%
Dec 31, 2022	146.52B	26.24B	21.81%
Dec 31, 2021	120.28B	10.09B	9.16%
Dec 31, 2020	110.19B	63.79B	137.47%